Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
MM-434: Identifying Circulating Tumor Cells via Advanced Flow Cytometry as Emerging Prognostic Indicators in Patients With Asymptomatic Monoclonal Gammopathies
Konstantinos Giannakas, Panagiotis Malandrakis, Ioannis V. Kostopoulos, Ioannis Ntanasis‐Stathopoulos, Eirini Solia, Foteini Theodorakakou, Vasiliki Spiliopoulou, Despina Fotiou, Magdalini Migkou, Nikolaos Kanellias, Μαρία Ρούσσου, Evangelos Eleutherakis‐Papaiakovou, Kostantina Taouxi, Alexandra Papadimou, Christine‐Ivy Liacos, Maria Gavriatopoulou, Ourania Tsitsilonis, Evangelos Terpos, Efstathios Kastritis, Meletios A Dimopoulos (2025). MM-434: Identifying Circulating Tumor Cells via Advanced Flow Cytometry as Emerging Prognostic Indicators in Patients With Asymptomatic Monoclonal Gammopathies. , 25, DOI: https://doi.org/10.1016/s2152-2650(25)02604-7.
Article43 days agoPOSTER: MM-434 Identifying Circulating Tumor Cells via Advanced Flow Cytometry as Emerging Prognostic Indicators in Patients With Asymptomatic Monoclonal Gammopathies
Konstantinos Giannakas, Panagiotis Malandrakis, Ioannis V. Kostopoulos, Ioannis Ntanasis‐Stathopoulos, Eirini Solia, Foteini Theodorakakou, Vasiliki Spiliopoulou, Despina Fotiou, Magdalini Migkou, Nikolaos Kanellias, Μαρία Ρούσσου, Evangelos Eleutherakis‐Papaiakovou, Kostantina Taouxi, Alexandra Papadimou, Christine‐Ivy Liacos, Maria Gavriatopoulou, Ourania Tsitsilonis, Evangelos Terpos, Efstathios Kastritis, Meletios A Dimopoulos (2025). POSTER: MM-434 Identifying Circulating Tumor Cells via Advanced Flow Cytometry as Emerging Prognostic Indicators in Patients With Asymptomatic Monoclonal Gammopathies. , 25, DOI: https://doi.org/10.1016/s2152-2650(25)01259-5.
Article43 days agoDeterminants of 15‐Year Progression‐Free Survival in Multiple Myeloma; Real‐World Data From a Single Institution
Meletios A Dimopoulos, Ioannis Ntanasis‐Stathopoulos, Despina Fotiou, Foteini Theodorakakou, Eirini Solia, Vasiliki Spiliopoulou, Panagiotis Malandrakis, Erasmia Psimenou, Stavroula Giannouli, Nikolaos Kanellias, Vassilis Koutoulidis, Μαρία Ρούσσου, Αngeliki Andrikopoulou, Magdalini Migkou, Evangelos Eleutherakis‐Papaiakovou, Maria Gavriatopoulou, Evangelos Terpos, Efstathios Kastritis (2025). Determinants of 15‐Year Progression‐Free Survival in Multiple Myeloma; Real‐World Data From a Single Institution. , 100(10), DOI: https://doi.org/10.1002/ajh.70012.
Article43 days agoRe-evaluation of Mayo 2004 and revised Mayo 2012 staging in patients with AL amyloidosis in the era of new therapies
Foteini Theodorakakou, Despina Fotiou, Vasiliki Spiliopoulou, Magdalini Migkou, Panagiotis Malandrakis, Ioannis Ntanasis-Stathopoulos, Μαρία Ρούσσου, Nikolaos Kanellias, Evangelos Eleutherakis‐Papaiakovou, Eirini Solia, Asimina Papanikolaou, Charikleia Gakiopoulou, Julie Courraud, Panagiota Nikolaou, Stavroula Giannouli, Maria Gavriatopoulou, Evangelos Terpos, Meletios A Dimopoulos, Efstathios Kastritis (2025). Re-evaluation of Mayo 2004 and revised Mayo 2012 staging in patients with AL amyloidosis in the era of new therapies. , 32(2), DOI: https://doi.org/10.1080/13506129.2025.2456790.
Article43 days agoOutcomes of Venetoclax in Patients with Relapsed or Refractory AL Amyloidosis
Foteini Theodorakakou, Despina Fotiou, Vasiliki Spiliopoulou, Magdalini Migkou, Panagiotis Malandrakis, Ioannis Ntanasis-Stathopoulos, Μαρία Ρούσσου, Nikolaos Kanellias, Evangelos Eleutherakis‐Papaiakovou, Eirini Solia, Asimina Papanikolaou, Charikleia Gakiopoulou, Maria Gavriatopoulou, Evangelos Terpos, Meletios A Dimopoulos, Efstathios Kastritis (2024). Outcomes of Venetoclax in Patients with Relapsed or Refractory AL Amyloidosis. , 144(Supplement 1), DOI: https://doi.org/10.1182/blood-2024-203780.
Article43 days ago